Evidence map›Paper›PMID 32779774›Full record

SynthesisJournal of gastroenterology and hepatology2020

Incidence of SARS-CoV-2 infection in inflammatory bowel disease.

M H Lee, C H Ng, Y H Chin, M Muthiah, F J Foo, C S Chong

Open access · bronzeAbstract readLetterMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of gastroenterology and hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Incidence of SARS-CoV-2 infection in inflammatory bowel disease.Journal of gastroenterology and hepatology · 2020
    Pooled it
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

M H LeeDepartment of Biological Sciences, Faculty of Science, National University of Singapore, Singapore.
C H NgYong Loo Lin School of Medicine, National University of Singapore, Singapore.
Y H ChinYong Loo Lin School of Medicine, National University of Singapore, Singapore.
M MuthiahYong Loo Lin School of Medicine, National University of Singapore, Singapore.
F J FooDepartment of General Surgery, Sengkang General Hospital, Singapore.
C S ChongYong Loo Lin School of Medicine, National University of Singapore, Singapore.ORCID https://orcid.org/0000-0003-0669-7307
National University of Singapore · SGSengkang General Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsCOVID-19HumansIncidenceInflammatory Bowel DiseasesSARS-CoV-2Biological Products

Identifiers

PMID32779774
PMCPMC7404756
OpenAlexW3043987825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.